Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia

Environmental and Molecular Mutagenesis

Volumn 41, Issue 1, 2003, Pages 69-76

  Sierra Torres, Carlos H ^a,b   Au, William W ^a   Arrastia, Concepcion D ^a   Cajas Salazar, Nohelia ^a,b   Robazetti, Sonia C ^a   Payne, Deborah A ^a   Tyring, Stephen K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD DEL CAUCA   (Colombia)

Author keywords

Cervicol neoplasia; CYP2E1; Genetic susceptibility; GSTM1; Human papillomavirus; Microsomol epoxide hydrolase; Molecular epidemiology; Polymorphic metabolizing genes

Indexed keywords

CARCINOGEN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METABOLISM; RISK FACTOR; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 0037258372     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10132     Document Type: Article

References (62)

1. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, Armes JE. 2000. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 83:1659-663.
2. Bartsch H, Hietanen E. 1996. The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104 Suppl 3:569-577.
3. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Stidley CA, Jamison SF, Jordan SW. 1994. Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 3:113-119.
4. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. 1993. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164.
5. Board PG. 1981. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 33:36-43.
6. Bonnez W. 2000. The 18th International Papillomavirus Conference. Antivir Ther 5:279-283.
7. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC. 1992. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52:750-758.
8. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
9. Brinton LA. 1992. Epidemiology of cervical cancer: overview. IARC Sci Publ 119:3-23.
10. Carriere V, Berthou F, Baird S, Belloc C, Beaune P, de Waziers I. 1996. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 6:203-211.
11. Charrier J, Maugard CM, Le Mevel B, Bignon YJ. 1999. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility. Br J Cancer 79:346-353.
12. Chen C, Madeleine MM, Weiss NS, Daling JR. 1999. Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study. Am J Epidemiol 150:568-572.
13. Daly SF, Doyle M, English J, Turner M, Clinch J, Prendiville W. 1998. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears? Am J Obstet Gynecol 179:399-402.
14. El-Zein R, Zwischenberger JB, Wood TG, Abdel-Rahman SZ, Brekelbaum C, Au WW. 1997a. Combined genetic polymorphism and risk for development of lung cancer. Mutat Res 381:189-200.
15. El-Zein RA, Zwischenberger JB, Abdel-Rahman SZ, Sankar AB, Au WW. 1997b. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett 112:71-78.
16. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. 1994. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69:114-119.
17. Goodman MT, McDuffie K, Hernandez B, Bertram CC, Wilkens LR, Guo C, Seifried A, Killeen J, Le Marchand L. 2001. CYP1A1, GSTM1 and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81:263-269.
18. Guengerich FP. 1982. Epoxide hydrolase: properties and metabolic roles. Rev Biochem Toxicol 4:5-30.
19. Guengerich FP, Kim DH, Iwasaki M. 1991. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
20. Hassett C, Aicher L. Sidhu JS, Omiecinski CJ. 1994. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428.
21. Haverkos H, Rohrer M, Pickworth W. 2000. The cause of invasive cervical cancer could be multifactorial. Biomed Pharmacother 54:54-59.
22. Hayashi S, Watanabe J, Kawajiri K. 1991. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem (Tokyo) 110:559-565.
23. Hayes JD, Pulford DJ. 1995. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600.
24. Heagerty AH, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L, Alldersea J, Strange RC. 1994. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 343:266-268.
25. Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E. 1988. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 158:910-913.
26. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK. 1997. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207-1212.
27. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
28. Holowaty P, Miller AB, Rohan T, To T. 1999. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252-258.
29. International Agency for Research on Cancer. 1986. Monograph on the evaluation of the carcinogenic risk of chemicals to humans. IARC Sci Publ 38:1-421.
30. Kalogeraki A, Tamiolakis D, Tzardi M, Datseris G, Karvelas K, Kanavaros P, Delides G. 1996. Cigarette smoking as a risk factor for intraepithelial lesion of the cervix uteri. In Vivo 10:613-616.
31. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. 1995. Human lung carcinogen adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 87:902-907.
32. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A. Kuroki N, Ookuma R, Bell DA. 1996. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17:1855-1859.
33. Kim JW, Lee CG, Park YG, Kim KS, Kim IK, Sohn YW, Min HK, Lee JM, Namkoong SE. 2000. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88:2082-2091.
34. Kjaer SK, Engholm G, Dahl C, Bock JE. 1996. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark: IV, role of smoking habits. Eur J Cancer Prev 5:359-365.
35. Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, Wiseman RW, Taylor JA. 1996. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17:160-162.
36. Landis SH, Murray T, Bolden S, Wingo PA. 1998. Cancer statistics, 1998. CA Cancer J Clin 48:6-29.
37. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM. 1992. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1:125-129.
38. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoe-Bonnie A, Ofori-Adjei D. 1995. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92:2384-2387.
39. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
40. National Institutes of Health. 1996. Cervical cancer. NIH Consensus Statement 14:1-38.
41. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. 1996. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
42. Norppa H. 1997. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect 105(Suppl):829-835.
43. Pelkonen O, Raunio H, Rautio A, Lang M. 1999. Chapter 8. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype. IARC Sci Publ 148:77-88.
44. Persson I, Johansson I, Bergling H, Dahl ML, Seidegard J, Rylander R, Rannug A, Hogberg J, Sundberg MI. 1993. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 319:207-211.
45. Pizzighella S, Pisoni G, Bevilacqua F, Vaona A, Palu G. 1995. Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection. J Virol Methods 55:245-256.
46. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. 1997. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89:868-873.
47. Salama SA, Sierra-Torres CH, Oh HY, Hamada FA, Au WW. 1999. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping. Cancer Lett 143:51-56.
48. Salama SA, Sierra-Torres CH, Oh HY, Hamada FA, Au WW. 2001. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ Mol Mutag 37:17-26.
49. Schneider A, Kirchhoff T, Meinhardt G, Gissmann L. 1992. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Gynecol 79:683-688.
50. Seidegard J, DePierre JW. 1983. Microsomal epoxide hydrolase: properties, regulation and function. Biochim Biophys Acta 695:251-270.
51. Simons AM, Phillips DH, Coleman DV. 1993. Damage to DNA in cervical epithelium related to smoking tobacco. Br Med J 306:1444-1448.
52. Simons AM, Mugica van Herckenrode C, Rodriguez JA, Maitland N, Anderson M, Phillips DH, Coleman DV. 1995. Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer 71:246-249.
53. Sims P, Grover PL, Swaisland A, Pal K, Hewer A. 1974. Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature 252:326-328.
54. Smith CA, Harrison DJ. 1997. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630-633.
55. Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. 2001. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 22:67-72.
56. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. 2001. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10:875-882.
57. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H. 2002. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 33:98-102.
58. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
59. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, Jones P, Alldersea J, Gilford J, Yengi L. 1994a. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15:2841-2845.
60. Warwick AP, Redman CW, Jones PW, Fryer AA. Gilford J, Alldersea J, Strange RC. 1994b. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer 70:704-708.
61. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, Manos MM. 1993. Determinants of genital human papilloma-virus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 20:286-289.
62. zur Hausen H. 1996. Papillomavirus infections: a major cause of human cancers. Biochem Biophys Acta 1288:F55-F78.